OpenScience.ink

1 month ago • Obesity pillars

Clinical importance of lowest weight and weight regain over 3 years of tirzepatide treatment in people with obesity or overweight and prediabetesEvaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes.

📖 Top 20% JournalArticle

1 month ago • Best practice & research. Clinical rheumatology

New understanding of how osteoporosis develops and personalized treatment approachesNew insights into the pathogenesis of osteoporosis and the translational approach to personalized therapy.

🎖️ Top 10% JournalArticle

1 month ago • JAMA pediatrics

Weight-Loss Surgery and Use of Blood Sugar Control Medicines in TeenagersMetabolic and Bariatric Surgery and GLP-1 Receptor Agonist Use Among Adolescents.

🥇 Top 1% JournalArticle

1 month ago • Advances in therapy

How Medicaid Patients Follow and Factors Affecting Use of GLP-1 Drugs for Managing ObesityReal-World Adherence Patterns and Predictors of GLP-1 Receptor Agonist Use for Obesity Management in a Medicaid Population.

📖 Top 20% JournalArticle

1 month ago • EClinicalMedicine

Stroke risk linked to SGLT2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors in people with type 2 diabetes in SwedenThe effect of SGLT2 inhibitors, GLP-1 receptor agonists, or DPP-4 inhibitors on stroke risk in type 2 diabetes: a nationwide longitudinal cohort study in Sweden with contextualisation analysis.

🥈 Top 2% JournalArticle

1 month ago • European journal of internal medicine

New comprehensive treatment approaches for creatine kinase muscle diseaseInnovative holistic treatment for CKM: what lies ahead?

📖 Top 20% JournalArticle

1 month ago • American journal of preventive cardiology

Study setup and starting details of a phase 3 trial testing the oral drug orforglipron for high blood pressureStudy design, rationale, and baseline characteristics of ATTAIN-HYPERTENSION, a phase 3 trial of the oral GLP-1 receptor agonist orforglipron for hypertension.

🥉 Top 5% JournalArticle

2 days ago • Indian journal of pharmacology

Severe low blood sodium linked to tirzepatide with signs of inappropriate antidiuretic hormone releaseTirzepatide-associated severe euvolemic hyponatremia with syndrome of inappropriate antidiuretic hormone secretion-compatible biochemical features.

📖 Top 50% JournalCase Reports

1 week ago • The Journal of international medical research

Severe acid imbalance linked to starvation after short-term use of oral semaglutide: A case reportStarvation-associated high-anion gap metabolic acidosis following short-term oral semaglutide use: A case report.

📖 Top 50% JournalCase Reports

3 weeks ago • Canadian journal of physiology and pharmacology

How Incretin Hormones Work: New Advances from Research to TreatmentIncretins in Action: Unlocking New Frontiers from Bench to Bedside.

📖 Top 50% JournalIntroductory Journal Article

2 days ago • Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

GLP-1 increases IL-27 production in immune cells by activating the PI3K/AKT signaling pathwayGLP-1 Enhances IL-27 Production in RAW264.7 Macrophages Via Activation of the PI3K/AKT Pathway.

📖 Top 30% JournalArticle

2 days ago • Balkan medical journal

Comparing GLP-1 Receptor Agonists with Empagliflozin or Dapagliflozin in People with Fatty Liver Disease and Heart FailureGLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study.

📖 Top 30% JournalArticle

5 days ago • BMC cardiovascular disorders

Glucagon-like peptide-1 drugs and the risk of heart rhythm problems in people with heart attack and type 2 diabetesGlucagon-like peptide-1 receptor agonists and the risk of ventricular arrhythmia in patients with acute myocardial infarction and type 2 diabetes mellitus: a propensity score-matched cohort study.

📖 Top 30% JournalArticle

6 days ago • Expert opinion on pharmacotherapy

Guidelines for Switching Between Semaglutide and Tirzepatide at Similar Effectiveness Levels in Obesity TreatmentSwitching between semaglutide and tirzepatide in obesity Management: an expert-consensus framework for approximate clinical Efficacy-matched switching doses.

📖 Top 30% JournalArticle

1 week ago • Diabetes, metabolic syndrome and obesity : targets and therapy

Pancreatic and Gallbladder Problems Linked to Tirzepatide Use for ObesityPancreatic and Gallbladder Adverse Events Associated with Tirzepatide in Obesity Management: A Scoping Review.

📖 Top 30% JournalArticle

1 week ago • Diabetes, metabolic syndrome and obesity : targets and therapy

Effects of Incretin-Based Treatments on Body Measurements and Metabolism in Women with Polycystic Ovary SyndromeThe Impact of Incretin-Based Therapies on Anthropometric and Metabolic Parameters in Women with Polyendocrine Metabolic Ovarian Syndrome.

📖 Top 30% JournalArticle

1 week ago • Clinics in dermatology

How GLP-1 Receptor Agonists Affect Diabetic Foot Problems: Causes, Clinical Findings, and Treatment TipsGLP-1 Receptor Agonists and the Diabetic Foot: Mechanisms, Clinical Evidence, and Practical Considerations.

📖 Top 50% JournalArticle

1 week ago • Journal of the Endocrine Society

How well liraglutide works for children with type 2 diabetes in everyday lifeReal-world effectiveness of liraglutide in children with type 2 diabetes.

📖 Top 20% JournalArticle

1 week ago • BMC pharmacology & toxicology

Reports of brain-related side effects from GLP-1 diabetes treatments based on global safety dataNeuropsychiatric adverse event reporting with GLP-1-based therapies: a post-marketing pharmacovigilance analysis using the WHO global individual case safety report database (VigiBase).

📖 Top 30% JournalArticle

1 week ago • Clinical nutrition ESPEN

Low sodium levels are linked to how patients with short bowel syndrome respond to glepaglutideSodium depletion is associated with the response to glepaglutide in short bowel syndrome with chronic intestinal failure.

📖 Top 30% JournalArticle

1 week ago • International journal of preventive medicine

Recent Global Research Trends in Ozempic, Weight Loss, and PancreatitisVisualizing Emerging Trends and Global Hotspots in Ozempic, Weight Loss, and Pancreatitis Research: A Scientometric Analysis.

📖 Top 50% JournalArticle

1 week ago • Journal of laparoendoscopic & advanced surgical techniques. Part A

Factors linked to not moving forward with weight-loss surgery in very severely obese patients at a community centerClosing the Gap to Bariatric Surgery: Predictors of Non-Progression in Patients with Obesity Class IV and V at a Community-Based Bariatric Center.

📖 Top 50% JournalArticle

1 week ago • International journal of medical sciences

Link Between Using GLP-1 Medicines and Thyroid Health in Adults with Type 2 DiabetesAssociation of GLP-1 Receptor Agonist Use with Thyroid Outcomes in Adults with Type 2 Diabetes.

📖 Top 20% JournalArticle

1 week ago • European journal of clinical pharmacology

GLP-1 Treatments for Heart Disease: Results, How They Work, and New Medical UsesGLP-1-based therapies in cardiovascular disease: outcomes, mechanisms, and emerging clinical applications.

📖 Top 20% JournalArticle

1 week ago • Neuroendocrinology

Butyrate may boost Semaglutide’s effect on reducing obesityButyrate enhances the obesity reduction effect of Semaglutide.

📖 Top 20% JournalArticle

1 week ago • Central European journal of urology

What Urologists Should Know About Weight Loss and Kidney Stones with Glucagon-Like Peptide-1 Receptor AgonistsGlucagon-like peptide-1 receptor agonists, weight loss, and urolithiasis: what urologists should know.

📖 Top 50% JournalArticle

1 week ago • Advances in anesthesia

Glucagon-Like Peptide-1 Receptor Agonists: Updated Information on Surgery-Related Effects and GuidelinesAn Updated Review of Glucagon-Like Peptide-1 Receptor Agonists: Perioperative Implications, Guidance Statements, and Current Literature.

📖 Top 50% JournalArticle

1 week ago • Advances in anesthesia

Managing Blood Sugar Medicines Around SurgeryPerioperative Management of Antihyperglycemic Medications.

📖 Top 50% JournalArticle

2 weeks ago • Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Use and effects of diabetes drugs on people being evaluated for kidney transplant in British ColumbiaPrescribing patterns and impact of glucagon-like peptide-1 receptor agonists in a kidney transplant evaluation cohort in British Columbia, Canada A single-center experience.

📖 Top 30% JournalArticle

2 weeks ago • Clinics and research in hepatology and gastroenterology

How Different Doses of Incretin and Multi-Target Drugs Affect Weight LossDose-Response Profiles in Incretin and Multi-Agonist Obesity Pharmacotherapy.

📖 Top 30% JournalArticle

← prevpage 10 of 16next →

GLP-1 Therapies Research Papers